Dyne Therapeutics(DYN) - 2025 Q4 - Annual Results

Financial Position - Dyne Therapeutics expects to report cash, cash equivalents, and marketable securities of approximately $1.1 billion as of December 31, 2025[5] - The estimated cash figure is preliminary and unaudited, subject to completion of the Company's financial closing procedures[6] Investor Communication - A presentation discussing the Company's current operations and future plans was made available to investors on January 12, 2026[8]